Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 450 of 869 entries
View as:

Plasma Proteomic Biomarkers for Early Diagnosis of Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05742204 Org: User:
Start: 02/01/23 End: 10/31/32 Due: 10/31/33

High-flow Nasal Cannula Oxygen Therapy With the Chest Trauma Patients

Phase: N/A Priority: Normal
NCT ID: NCT03430258 Org: User:
Start: 03/01/18 End: 03/30/19 Due: 03/30/20

the Application of Diffusion Tensor Imaging in the Evaluation of Peripheral Neuropathy in ANCA Associated Vasculitis

Phase: N/A Priority: Normal
NCT ID: NCT04923074 Org: User:
Start: 07/31/21 End: 07/31/23 Due: 07/31/24

Real-world Analysis on the Efficacy and Safety of Neoadjuvant Therapy for Head and Neck Squamous Cell Carcinoma （neoHNSCC）

Phase: N/A Priority: Normal
NCT ID: NCT06011993 Org: User:
Start: 07/19/23 End: 12/01/23 Due: 12/01/24

Hippocampal and Thalamic DBS for Bilateral Temporal Lobe Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT04164056 Org: User:
Start: 11/30/19 End: 09/30/24 Due: 09/30/25

Effect of Hypocalcemia on the Outcome of Elderly Major Trauma Patients With Trauma-induced Coagulopathy

Phase: N/A Priority: Normal
NCT ID: NCT05530161 Org: User:
Start: 01/01/15 End: 09/01/23 Due: 09/01/24

The Effect of Nutrition-optimized Prehabilitation on Perioperative Intervention in Primary Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06549829 Org: User:
Start: 09/01/24 End: 01/31/26 Due: 01/31/27

Related Studies of Imaging Features and Prognosis Between Pancreatic Neuroendocrine Tumors and Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04977596 Org: User:
Start: 01/01/12 End: 06/25/19 Due: 06/25/20

A Modified Method for Blind Bedside Placement of Post-pyloric Feeding Tube.

Phase: N/A Priority: Normal
NCT ID: NCT04608071 Org: User:
Start: 01/01/17 End: 10/30/19 Due: 10/30/20

Diagnosis of Lynch Syndrome Based on Next-generation Sequencing in Patients Meeting Chinese Lynch Syndrome Criteria

Phase: N/A Priority: Normal
NCT ID: NCT03046849 Org: User:
Start: 03/08/17 End: 02/26/19 Due: 02/26/20

Safety and Effectiveness of Extended Circumferential Decompression for Thoracic Ossification of Posterior Longitudinal Ligament

Phase: N/A Priority: Normal
NCT ID: NCT04910737 Org: User:
Start: 06/08/20 End: 04/01/21 Due: 04/01/22

Prospective, Multicenter Cohort Study on the Safety and Efficacy of Treatment for Middle Cerebral Artery Aneurysms

Phase: N/A Priority: Normal
NCT ID: NCT04927520 Org: User:
Start: 06/05/21 End: 12/31/24 Due: 12/31/25

Effectiveness and Safety of Ustekinumab Intensification in Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT05705856 Org: User:
Start: 02/15/23 End: 06/01/24 Due: 06/01/25

Phase II Clinical Trial Scheme of Ganoderma Lucidum Spore Powder for Postoperative Chemotherapy of Osteosarcoma

Phase: N/A Priority: Normal
NCT ID: NCT04319874 Org: User:
Start: 09/15/20 End: 09/15/25 Due: 09/15/26

Anlotinib Hydrochloride For Advanced Soft Tissue Sarcoma Patients Who Do Not Receive Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT03792542 Org: User:
Start: 01/31/19 End: 12/31/20 Due: 12/31/21

Construction and Application of Early Lung Rehabilitation Training Programs

Phase: N/A Priority: Normal
NCT ID: NCT04912986 Org: User:
Start: 04/01/21 End: 12/30/23 Due: 12/30/24

Neoantigen Vaccine in Esophagus Cancer Patients Following Neoadjuvant Therapy and Surgical Resection

Phase: N/A Priority: Normal
NCT ID: NCT05307835 Org: User:
Start: 12/02/21 End: 12/03/25 Due: 12/03/26

Endovascular Thrombectomy With and Without Intravenous Thrombolysis in Extended Time Window

Phase: N/A Priority: Normal
NCT ID: NCT05634382 Org: User:
Start: 12/03/22 End: 02/28/25 Due: 02/28/26

Efficacy of an Ocular Bandage Contact Lens for the Treatment of Dry Eye After Cataract Surgery

Phase: N/A Priority: Normal
NCT ID: NCT04100031 Org: User:
Start: 09/01/18 End: 12/06/20 Due: 12/06/21

Comparing Endoscopic Strictureplasty vs. Balloon Dilation in Crohn's Disease Strictures

Phase: N/A Priority: Normal
NCT ID: NCT06203782 Org: User:
Start: 12/16/24 End: 01/01/26 Due: 01/01/27

Combination With Sintilimab and XELOX+Bevacizumab as 1st Line Therapy in RAS-mutant Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05171660 Org: User:
Start: 02/08/22 End: 12/30/26 Due: 12/30/27

Rectal Artery Infusion Chemotherapy Combined With Anti-PD1 Antibody for MSS LARC

Phase: N/A Priority: Normal
NCT ID: NCT05307198 Org: User:
Start: 05/11/22 End: 04/25/25 Due: 04/25/26

Surgical Treatment of Marfan Syndrome With Subluxation Lens

Phase: N/A Priority: Normal
NCT ID: NCT05578469 Org: User:
Start: 01/01/16 End: 12/30/24 Due: 12/30/25

Dissecting the Mechanism of DNA Methylation on the Invasiveness of Pituitary Tumors.

Phase: N/A Priority: Normal
NCT ID: NCT05634655 Org: User:
Start: 01/01/22 End: 01/01/25 Due: 01/01/26

The Effects of Preoperative Bevacizumab on Perioperative Complications

Phase: N/A Priority: Normal
NCT ID: NCT04788381 Org: User:
Start: 04/01/21 End: 07/31/21 Due: 07/31/22